Skip to main content

Table 2 Quality assessment criteria

From: A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease

 

Score

 

3

2

1

0

Patients at baseline, number

>151

101 to 150

51 to 100

<50

Follow-up time, years

>3 or mean ≥

3

2

Clinical criteria

Established criteria for AD + DLB criteria from 2005

Established criteria for AD + DLB criteria from 1992 or 1996

Used criteria for one type of dementia

No criteria used

Autopsy, % of participants

100

>50

>25

None

  1. AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; BNT, Boston naming test; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease evaluation; DRS, dementia rating scale; ESD, extended scale for dementia; HVLT-R Hopkins verbal learning test-revised; mMMS, modified mini-mental state examination; MMSE, mini mental state examination; MTS, 37 item mental test score.